) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day up 0.2%. By the end of trading, Boston Scientific fell $0.18 (-1.9%) to $9.03 on average volume. Throughout the day, 28,388,392 shares of Boston Scientific exchanged hands as compared to its average daily volume of 19,329,300 shares. The stock ranged in price between $9.02-$9.41 after having opened the day at $9.31 as compared to the previous trading day's close of $9.21. Other companies within the Health Care sector that declined today were:
), down 65.0%,
), down 10.2%,
), down 9.9% and
), down 9.1%.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $12.3 billion and is part of the health services industry. Shares are up 60.7% year to date as of the close of trading on Monday. Currently there are 5 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 14 rate it a hold.
TheStreet Ratings rates
. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow and feeble growth in its earnings per share.
- You can view the full Boston Scientific Ratings Report.
On the positive front,
), up 42.8%,
), up 17.5%,
), up 14.2% and
), up 13.0% , were all gainers within the health care sector with
) being today's featured health care sector leader.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider
) while those bearish on the health care sector could consider
- Find other investment ideas from our top rated ETFs lists.